Screener
Iovance Biotherapeutics, Inc. IOVA Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Iovance Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The source filing: Iovance Biotherapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 9:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091716
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Total costs and expenses | $151,218 | $173,726 | $303,691 | $344,271 |
| Loss from operations | (51,905) | (113,774) | (132,948) | (234,995) |
| Other income | ||||
| Interest and other income, net | 3,217 | 4,104 | 4,550 | 7,324 |
| Net Loss before income taxes | $(48,688) | $(109,670) | $(128,398) | $(227,671) |
| Income tax benefit (expense) | 1,373 | (1,988) | 2,038 | (150) |
| Net Loss | $(47,315) | $(111,658) | $(126,360) | $(227,821) |
| Net Loss Per Share of Common Stock, Basic and Diluted | $(0.11) | $(0.33) | $(0.29) | $(0.69) |
Item 1.Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Iovance Biotherapeutics, Inc.'s interest income?
- Iovance Biotherapeutics, Inc. (IOVA) reported interest income of $3.22M in Q2 2026.
- How has Iovance Biotherapeutics, Inc.'s interest income changed year-over-year?
- Iovance Biotherapeutics, Inc.'s interest income decreased by 21.6% year-over-year, from $4.1M to $3.22M.
- What is the long-term trend for Iovance Biotherapeutics, Inc.'s interest income?
- Over 4 years (2021 to 2025), Iovance Biotherapeutics, Inc.'s interest income has grown at a 118.6% compound annual growth rate (CAGR), from $451K to $10.31M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.
Ask your AI about Iovance Biotherapeutics, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude